Evidence-gap map · non-drug interventions

Attention Deficit-Hyperactivity Disorder evidence gaps

475 registered non-drug trials, mapped by approach and outcome.

  1. Research Tracker
  2. Evidence-gap maps
  3. Attention Deficit-Hyperactivity Disorder

Which non-drug approaches have been tested for Attention Deficit-Hyperactivity Disorder, and which outcomes they were tested on. An empty cell means no matching trial was found among those searched: a possible gap, not proof that nobody has asked the question.

475registered non-drug trials
48with results posted
62recruiting as of 2026-11-16
93group × outcome cells with at least one trial
⚠️
Research information, not medical advice. These pages index what has been studied in registered trials. A trial existing, completing or posting results says nothing on its own about whether an approach works or is safe for you. Supplements and devices can interact with medicines. Discuss any change with your own clinician.

Evidence-gap matrix

Each number is the count of trials; "with results" is how many of them have posted results on ClinicalTrials.gov. A trial is counted once per group and per outcome domain it covers. The number in brackets after each group is its total trials for this condition. The registry search returned 1,012 trials, more than the 1,000-trial cap, so this map covers the most recently updated 1,000.

none1–23–910–2930 or more
Registered non-drug trials for Attention Deficit-Hyperactivity Disorder by intervention group and primary outcome domain
Intervention groupFatigue and energyPost-exertional symptomsCognitionMood, anxiety and wellbeingPainSleepPhysical function and exercise capacityHeart rate, blood pressure and autonomicBreathing and lung functionQuality of lifeWeight and metabolic markersInflammation and other biomarkersSymptom severity and disease activityClinical events, survival and healthcare useFeasibility, adherence and safetyNot classified
Exercise and physical activity (33)··186··51·1·313·211 with results
Rehabilitation and therapy services (14)··82··2··2··2·12
Breathing and respiratory training (6)··32·······12··1
Mind-body and psychological approaches (79)1·291 with results22·242·3·2443 with results·131 with results8
Cognitive training and education (49)·12110·12··211172 with results·71 with results41 with results
Diet, fasting and nutrition (6)··41·1···1·341 with results···
Sleep and circadian approaches (11)··42 with results··82 with results······52 with results·21 with results·
Neuromodulation and electrical stimulation (48)··233 with results2·······4223 with results·46
Oxygen, light, temperature and manual therapies (7)··21·11 with results1·····4···
Supplements and nutraceuticals (40)··153 with results31 with results·42 with results1···23204 with results·31 with results61 with results
Other devices and digital tools (23)··91 with results321 with results·11·1·191 with results·11 with results4
Care delivery and health services (5)···1··1··1··21 with results·12
Other behavioural, not yet classified (191)1·494 with results372 with results1552·7251 with results8014 with results11 with results351 with results496 with results

The table scrolls sideways: 16 outcome columns.

Where the gaps are

This condition has 1,012 matching trials, more than the 1,000 this map covers, so it cannot show that an outcome was never measured. Only studied-but-unreported questions are listed.

Questions studied but with no results posted

  • Mind-body and psychological approaches × mood, anxiety and wellbeing: 22 trials registered, none with results posted (3 still recruiting)
  • Cognitive training and education × cognition: 21 trials registered, none with results posted (2 still recruiting)
  • Exercise and physical activity × cognition: 18 trials registered, none with results posted (1 still recruiting)
  • Exercise and physical activity × symptom severity and disease activity: 13 trials registered, none with results posted (2 still recruiting)
  • Cognitive training and education × mood, anxiety and wellbeing: 10 trials registered, none with results posted (2 still recruiting)
  • Rehabilitation and therapy services × cognition: 8 trials registered, none with results posted
  • Exercise and physical activity × mood, anxiety and wellbeing: 6 trials registered, none with results posted
  • Exercise and physical activity × physical function and exercise capacity: 5 trials registered, none with results posted
  • Mind-body and psychological approaches × physical function and exercise capacity: 4 trials registered, none with results posted (1 still recruiting)
  • Diet, fasting and nutrition × cognition: 4 trials registered, none with results posted (1 still recruiting)
  • Neuromodulation and electrical stimulation × inflammation and other biomarkers: 4 trials registered, none with results posted (2 still recruiting)
  • Neuromodulation and electrical stimulation × feasibility, adherence and safety: 4 trials registered, none with results posted (2 still recruiting)
  • Oxygen, light, temperature and manual therapies × symptom severity and disease activity: 4 trials registered, none with results posted (1 still recruiting)
  • Exercise and physical activity × inflammation and other biomarkers: 3 trials registered, none with results posted (1 still recruiting)

Design a trial with DecenTrial (beta) Fund a component of this work

A gap here means no matching trial was found among those searched, not that an approach would work. About one trial in six has primary outcomes the rules cannot classify, so a few gaps may be measured under another name. Some gaps are gaps for good reason.

Most-studied approaches for Attention Deficit-Hyperactivity Disorder

Download this matrix (CSV) Non-drug evidence map Evidence brief RepurpOS condition page Condition page

How outcomes are grouped

Each trial's primary outcome measures are sorted into domains by keyword rules. 77 trials for this condition have primary outcomes the rules could not classify; they appear in the last column rather than being dropped. Checked against 90 hand-labelled outcomes; on a held-out sample of 30, the rules agreed with the hand label for 20 before adjustment, and every outcome they labelled was labelled correctly (misses were left unclassified).

Trial selection and exclusions follow the non-drug evidence map method. Source: ClinicalTrials.gov, searched 2026-11-16.